Ben Goldacre launches Randomise Me trial software

Written by Web News Editor on . Posted in News

A new, free-to-use platform on which to conduct randomised control trials (RCT) has been developed by Dr Ben Goldacre in an effort to promote their wider use. enables individuals and organisations to run trials of varying sizes by taking them through a step by step process to create, structure and run a trial, including help to randomise the participants. Online tutorials are available on the site to get users started.
The platform can be used for questions ranging from ‘are my heart palpitations caused by drinking coffee?’ to ‘Will brain booster puzzles really help improve exam performance for the children I teach?’ Outcomes are measured and the statistical significance of any difference between them is calculated.
Ben Goldacre, author of The Guardian’s Bad Science column and subsequent book of the same name, has long supported the publication of all clinical trial results and published a book, Bad Pharma, on this very subject. He is also one of the founders of the AllTrials campaign, whose petition on the subject has so far gained more than 55,000 signatures.
Goldacre hopes the platform will make randomised control trials more accessible and generate better understanding of how they work. Footage of him speaking about the platform at its launch is available here.
The project has been backed by innovation charity Nesta, which hopes that Randomise Me will become the RCT equivalent of Survey Gizmo or Survey Monkey. ‘Our ambition is that Randomise Me will enable anyone to set up and turn their own trial, helping to robustly test different issues and interventions in an agile and low-cost way,’ it asserted on its blog.

Ben Goldacre Clinical trials

Join the RSS

Join the RSS

Become part of an organisation which works to advance statistics and support statisticians

Copyright 2019 Royal Statistical Society. All Rights Reserved.
12 Errol Street, London, EC1Y 8LX. UK registered charity in England and Wales. No.306096

Twitter Facebook YouTube RSS feed RSS feed RSS newsletter

We use cookies to understand how you use our site and to improve your experience. By continuing to use our site, you accept our use of cookies and Terms of Use.